Kastamonu Medical Journal regularly publishes internationally qualified issues in the field of Medicine in the light of up-to-date information.

EndNote Style
Case Report
Splenic artery aneurysm rupture after using enoxaparin for COVID-19: is it a coincidence or complication?
Splenic artery aneurysm is a rare and usually asymptomatic disease that is more common among women. It is usually diagnosed as a result of rupture during pregnancy. It may result in mortality if patients with rupture are not diagnosed and treated early. Although the endovascular method is the first choice in treatment, the surgical procedure can also be applied in hemodynamically unstable patients. In this report, we present a case of splenic artery aneurysm rupture that occurred due to the use of enoxaparin in a patient diagnosed with COVID-19 and followed up at home.

1. Fang G, Chen B, Fu W, et al. Strategies for endovascler treatment ofcomplicated splenic artery aneurysms. J Vasc Surg. 2018;68:787-794.
2. Pararas N, Rajendiran S, Taha I, Powar RR, Holguera C, Tadros E.Spontaneous rupture of a huge splenic artery aneurysm: a case report. AmJ Case Rep. 2020;21:e919956.
3. Kitamura H, Nakayama K, Kitano T, Ozaki N, Nagaoka S. Removal ofa splenic artery with a large aneurysm adhered to the pancreas withoutpancreatectomy: report of a case. Surg Taday. 2002;32(8):747-749.
4. Kehagias DT, Tzalonikos MT, Moulopoulos LA, Gouliamos AD, MourikisDA, Vlahos LJ. MRI of a giant splenic artery aneurysm. Br J Radiol.1998;71:444-446.
5. Abdulrahman A, Shabkah A, Hassanain M, Aljiffry M. Rupturedspontaneous splenic artery aneurysm: a case report and review of theliterature. Int J Surg Case Rep. 2014;5(10):754.
6. Liu CF, Kung CT, Liu BM, Ng SH, Huang CC, Ko SF. Splenic arteryaneurysms encountered in the ED: 10 years’ experience. Am J Emerg Med.2007;25:430-436.
7. Sadat U, Dar O, Walsh S, Varty K. Splenic artery aneurysms in pregnancy-asystematic review. Int J Surg. 2008;6:261-5.
8. Abbas MA, Stone WM, Fowl RJ, et al. Splenic artery aneurysms: twodecades experience at Mayo Clinic. Ann Vasc Surg. 2002;16(4):442-449.
9. Nincheri Kunz M, Pantalone D, Borri A, et al. Management of the splenicartery aneurysms. Two case reports and review of the literature. MinervaChir. 2003;58(2):247-256.
10. Muscari F, Bossavy JP, Chaufour X, Ghouti L, Barret A. Laparoscopicexclusion of a splenic artery aneurysma case report. Vasc EndovascularSurg. 2003;37:297-300
11. Arca MJ, Gagner M, Heniford BT, Sullivan TM, Beven EG. Splenic arteryaneurysms: methods of laparoscopic repair. J Vasc Surg. 1999;30:184-188.
12. Nadkarni GN, Lala A, Bagiella E, et al. Anticoagulation, bleeding,mortality, and pathology in hospitalized patients with COVID-19. J AmColl Cardiol. 2020; 76(16):1815-1826.
13. Moores L, Tritschler T, Brosnahan S, et al. Prevention, diagnosis, andtreatment of VTE in patients with coronavirus disease. 2019: CHESTGuideline and Expert Panel Report. Chest. 2020;158(3):1143-1163.
14. Spyropoulos AC, Levy JH, Ageno W, et al. Scientific and StandardizationCommittee communication: clinical guidance on the diagnosis,prevention, and treatment of venous thromboembolism in hospitalizedpatients with COVID-19. J Thromb Haemost. 2020:1859-1865.
15. Billet HH, Reyes-Gil M, Szymanski J, et al. Anticoagulation in COVID-19:effect of enoxaparin, heparin, and apixaban on mortality. Thromb Haemost.2020;120:1691-1699.
16. Botezatu C, Petrutescu M, Forminte M, Mastalier BS. Severe bleedingcomplications resulting in death following anticoagulant treatment inCOVID-19 surgical patients. Chirurgia. 2020;115(6):798-806.
17. Mattioli M, Benfaremo D, Mancini M, et al. Safety of intermediatedose of low molecular weight heparin in COVID-19 patients. J ThrombThrombolysis 2020;51:286-292. doi: 10.1007/s11239-020-02243-z.
18. Taylor S, Zvolensky MJ, Cox BJ, et al. Robust dimensions of anxietysensitivity: development and initial validation of the anxiety sensitivityindex-3. Psychological Assessment. 2007;19(2):176-188.
19. Cordova AC, Sumpio BE. Visceral artery aneurysms andpseudoaneurysms—should they all be managed by endovasculartechniques? Ann Vasc Dis. 2013;6(4):687-693.
Volume 3, Issue 2, 2023
Page : 110-112